Editorial: Navigating the landscape of IDH-mutant gliomas: advances in diagnosis, therapeutic management, and long-term monitoring - Top-Institutions - MDSpire

Editorial: Exploring the Realm of IDH-Mutant Gliomas: Progress in Diagnosis, Treatment Approaches, and Ongoing Patient Monitoring

  • By

  • Alessia Pellerino

  • Giulia Berzero

  • Francesco Bruno

  • July 21, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Neuro-oncology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Neuro-oncology

  • #3

    National Cancer Institute
    National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Oncology
    • Cancer Research

Original Source(s)

Editorial: Navigating the landscape of IDH-mutant gliomas: advances in diagnosis, therapeutic management, and long-term monitoring

  • by Alessia Pellerino, Giulia Berzero, Francesco Bruno

  • July 21, 2026

Related Content

STMN1 expression is associated with chemotherapy and immunotherapy efficacy in biliary tract cancer

Predicting cancer treatment outcomes using machine learning enabled clinical decision support systems

Preoperative 18F-FDG PET/CT as a surgical triage tool for synchronous neoplasm detection in acute left-sided obstructive colorectal cancer: a two-institution retrospective cohort study